Journal profile · PATHOLOGY
Pathologica
ISSN 0031-2983 · eISSN 1591-951X · Pacini Editore SpA
Pathologica: CAS Zone 4 · Medicine (2025 upgraded edition); fully open access; median 83 days to acceptance (80 articles, last 24 months); 74 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Pathologica is published by Pacini Editore SpA and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Sarcoma Diagnosis and Treatment, Metastasis and carcinoma case studies and Breast Lesions and Carcinomas, together about 24.1% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Pathologica is intended to provide a medium for the communication of results and ideas in the field of morphological research on human diseases in general and on human pathology in particular. The journal welcomes contributions concerned with experimental morphology, ultrastructural research, immunocytochemical analysis, and molecular biology. Reports of work in other fields relevant to the understanding of human pathology may be submitted as well all papers on the application of new methods and techniques in pathology.
From the journal's Aims & Scope
Research area (LetPub): PATHOLOGY
Editor-in-chief M. BarbareschiPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Sarcoma Diagnosis and TreatmentMedicine10.1%
- Metastasis and carcinoma case studiesMedicine7.1%
- Breast Lesions and CarcinomasMedicine6.9%
- History of Science and MedicineArts and Humanities5.1%
- Breast Cancer Treatment StudiesBiochemistry, Genetics and Molecular Biology4.5%
- AI in cancer detectionComputer Science4.5%
- Neuroendocrine Tumor Research AdvancesMedicine4.2%
- Research on Leishmaniasis StudiesMedicine4.2%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pathology | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Pathology | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
CiteScore quartiles (Scopus, June 2026 release)
| Subject | Quartile | Rank | Percentile |
|---|---|---|---|
| Pathology and Forensic Medicine | Q2 | 65/209 | 69th |
Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub
Database indexing
ESCIScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 4.3LetPub ·
- SJR 2026-06
- 0.92LetPub ·
- SNIP 2026-06
- 1.44LetPub ·
- h-index
- 31OpenAlex ·
- i10-index
- 94OpenAlex ·
- 2-year mean citedness
- 2.37OpenAlex ·
- Self-citation rate
- 7.1%LetPub ·
- Share of gold OA articles
- 99.33%LetPub ·
Volume
- Articles per year
- 67LetPub ·
Articles by year OpenAlex count · 648 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 31 | 31 | 1,094 |
| 2025 | 74 | 74 | 1,331 |
| 2024 | 50 | 50 | 1,118 |
| 2023 | 44 | 44 | 869 |
| 2022 | 56 | 56 | 494 |
| 2021 | 61 | 61 | 233 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
83 daysMedian, submission to acceptance · P25–P75 49 days – 143 days
- Acceptance to online
- median 127 days (3 articles)
- Submission to online
- median 134 days
- Sample
- 80 articles with submission and acceptance dates (111 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessOpenAlex
Every article is open access; authors usually pay an article processing charge (APC).
No source has fee information yet; check the journal's website.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Data availability, Publication ethics, License & copyright, Open access, Plagiarism
- AI use 08. Artificial Intelligence (AI) and AI-assisted technologies policy
Authors must disclose any use of artificial intelligence (AI) tools in the preparation of the manuscript. AI-assisted scientific writing refers to the use of AI systems to support the writing or scientific production process, including activities such as:
Source ↗Publisher website ·- Authorship 05. Authorship and Contributorship
Pathologica endorses the ICMJE criteria to define the roles of Authors and Contributors to justify authorship.
Source ↗Publisher website ·- Conflicts of interest 04. Conflict of Interest and Source of Funding
A conflict of interest occurs when any financial interest may influence the content of an article. This does not imply that any financial involvement with a sponsor who has supported research or funded a consultation is problematic.
Source ↗Publisher website ·- Data availability 03. Data Availability
To promote transparency of the data supporting the results reported in the article, the Journal encourages authors to provide a data availability statement, provided that the research data can be made public. This should be included at the end of the “Materials and Methods” section under a separate “Data availability” subheading. Data availability statement should include information on where data…
Source ↗Publisher website ·- Publication ethics PUBLICATION ETHICS AND MALPRACTICE STATEMENT
Ethical Approvals Informed Consent Data Availability Conflict of Interest and Source of Funding Authorship and Contributorship Acknowledgements Plagiarism and Malpractice Policy AI and AI-assisted technologies policy Use of generative AI and AI-assisted tools in figures, images and artwork Corrections and retractions
Source ↗Publisher website ·- License & copyright Copyright
Società Italiana di Anatomia Patologica e Citopatologia Diagnostica, Divisione Italiana della International Academy of Pathology
Source ↗Publisher website ·- Open access 03. Open Access Policy
As previously reported, the journal provides immediate open access to its content, respecting the idea of its founder that making research freely available to the public supports a greater global exchange of knowledge.
Source ↗Publisher website ·- Plagiarism 07. Plagiarism and Malpractice Policy
Authors must avoid any unethical and improper actions such as plagiarism, simultaneous submission, falsification, fraudulent authorship, copyright infringement, hiding of competing interests, etc. For further information:
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Pacini Editore SpA
- ISSN
- 0031-2983
- Electronic ISSN
- 1591-951X
- Society / sponsor
- Italian Society of Anatomic Pathology and Diagnostic Cytopathology
- Latest issue on the website
- Volume 118, Issue 3 (June 2026)
- Official links
- Journal homepage ↗OpenAlex
FAQ
Frequently asked questions about Pathologica
What CAS zone is Pathologica in?
In the 2025 upgraded edition of the CAS Journal Ranking, Pathologica is in Zone 4 of Medicine, and in Zone 3 of the minor category Pathology. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
How long does peer review take at Pathologica?
Based on the dates recorded on 80 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 83 days (interquartile range 49–143 days). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Pathologica?
According to LetPub and DOAJ records, Pathologica is indexed in ESCI and Scopus.
Is Pathologica open access, and what is the APC?
Pathologica is a fully open-access journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .